Yves Donazzolo

1.3k total citations
46 papers, 909 citations indexed

About

Yves Donazzolo is a scholar working on Pharmacology, Physiology and Epidemiology. According to data from OpenAlex, Yves Donazzolo has authored 46 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 9 papers in Physiology and 8 papers in Epidemiology. Recurrent topics in Yves Donazzolo's work include Diet and metabolism studies (5 papers), Influenza Virus Research Studies (4 papers) and Gastrointestinal motility and disorders (4 papers). Yves Donazzolo is often cited by papers focused on Diet and metabolism studies (5 papers), Influenza Virus Research Studies (4 papers) and Gastrointestinal motility and disorders (4 papers). Yves Donazzolo collaborates with scholars based in France, United States and Belgium. Yves Donazzolo's co-authors include Xavier Pelletier, Xavier Boulenc, Stéphanie Pépin, Franck Poitiers, William R. Brian, Robert Van Horn, Camille Salamand, Alvin Ibarra, Mélanie Saville and Arthur C. Ouwehand and has published in prestigious journals such as Gastroenterology, American Journal of Clinical Nutrition and Clinical Infectious Diseases.

In The Last Decade

Yves Donazzolo

44 papers receiving 874 citations

Peers

Yves Donazzolo
Geoffrey Warhurst United Kingdom
Shahriar Sedghi United States
Min Jiang China
Katherine Sun United States
Geoffrey Warhurst United Kingdom
Yves Donazzolo
Citations per year, relative to Yves Donazzolo Yves Donazzolo (= 1×) peers Geoffrey Warhurst

Countries citing papers authored by Yves Donazzolo

Since Specialization
Citations

This map shows the geographic impact of Yves Donazzolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Donazzolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Donazzolo more than expected).

Fields of papers citing papers by Yves Donazzolo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yves Donazzolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Donazzolo. The network helps show where Yves Donazzolo may publish in the future.

Co-authorship network of co-authors of Yves Donazzolo

This figure shows the co-authorship network connecting the top 25 collaborators of Yves Donazzolo. A scholar is included among the top collaborators of Yves Donazzolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yves Donazzolo. Yves Donazzolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klein, Joshua P., Thijs van Iersel, Daniel H. de Vries, Yves Donazzolo, & Ingrid Klingmann. (2025). Healthy participant engagement in early clinical trials: results from the European EUFEMED survey. Frontiers in Pharmacology. 16. 1540948–1540948.
2.
Duvauchelle, Thierry, Philippe Robert, Yves Donazzolo, et al.. (2022). Bioavailability and cardiovascular effects of adrenaline administered by Anapen 500 μg auto‐injector in healthy volunteers. British Journal of Clinical Pharmacology. 89(3). 1012–1019. 5 indexed citations
3.
Forssten, Sofia D., Alvin Ibarra, Jouni Junnila, et al.. (2022). Bifidobacterium animalis subsp. lactis Bi-07 supports lactose digestion in vitro and in randomized, placebo- and lactase-controlled clinical trials. American Journal of Clinical Nutrition. 116(6). 1580–1594. 9 indexed citations
4.
Breithaupt‐Grögler, Kerstin, Timothy C. Hardman, Jan de Hoon, et al.. (2019). The New First-in-Human EMA Guideline: Disruptive or Constructive? Outcomes From the First EUFEMED Discussion Forum. Frontiers in Pharmacology. 10. 398–398. 4 indexed citations
5.
Bortel, Luc Van, Hildegard Sourgens, Kerstin Breithaupt‐Grögler, et al.. (2018). EUFEMED London Conference 2017: Exploratory Medicines Development: Innovation and Risk Management. Frontiers in Pharmacology. 8. 901–901. 2 indexed citations
6.
Duvauchelle, Thierry, Philippe Robert, Yves Donazzolo, et al.. (2017). Bioavailability and Cardiovascular Effects of Adrenaline Administered by Anapen Autoinjector in Healthy Volunteers. The Journal of Allergy and Clinical Immunology In Practice. 6(4). 1257–1263. 31 indexed citations
7.
Alessi, Marie‐Christine, Christophe Gaudin, Valérie Martin, et al.. (2016). Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome. Cerebrovascular Diseases. 42(5-6). 404–414. 16 indexed citations
8.
Dupuis‐Girod, Sophie, Évelyne Decullier, Géraldine Samson, et al.. (2014). ELLIPSE Study. mAbs. 6(3). 793–798. 39 indexed citations
9.
Azpiroz, Fernando, et al.. (2014). Digestive Symptoms in Healthy People and Subjects With Irritable Bowel Syndrome. Journal of Clinical Gastroenterology. 49(7). e64–e70. 21 indexed citations
10.
Schlienger, Jean-Louis, François Paillard, Jean‐Michel Lecerf, et al.. (2014). Effect on blood lipids of two daily servings of Camembert cheese. An intervention trial in mildly hypercholesterolemic subjects. International Journal of Food Sciences and Nutrition. 65(8). 1013–1018. 11 indexed citations
11.
Paradis, Stéphanie, Magali Michaud, Marcel Culcasi, et al.. (2014). Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial. Journal of Translational Medicine. 12(1). 38–38. 28 indexed citations
12.
Gutierrez, Marcelo M., Laurent B. Nicolas, Yves Donazzolo, & Jasper Dingemanse. (2013). Relative bioavailability of a newly developed pediatric formulation of bosentan vs. the adult formulation. International Journal of Clinical Pharmacology and Therapeutics. 51(6). 529–536. 9 indexed citations
14.
Mocaër, Elisabeth, et al.. (2011). Absence of Psychostimulant Effects of a Supratherapeutic Dose of Tianeptine. Journal of Clinical Psychopharmacology. 31(4). 441–448. 13 indexed citations
15.
Patat, Alain, et al.. (2010). A safety grading scale to support dose escalation and define stopping rules for healthy subject first‐entry‐into‐man studies. British Journal of Clinical Pharmacology. 70(5). 736–748. 19 indexed citations
16.
Vliet, Diane van der, Stéphanie Pépin, Michel Lambert, et al.. (2010). Similar immunogenicity of the A/H1N1 2009 pandemic influenza strain when used as a monovalent or a trivalent vaccine. Human Vaccines. 6(10). 823–828. 15 indexed citations
17.
Carabin, Ioana G., Michael R. Lyon, Simon Wood, et al.. (2009). Supplementation of the diet with the functional fiber PolyGlycoplex®is well tolerated by healthy subjects in a clinical trial. Nutrition Journal. 8(1). 9–9. 35 indexed citations
18.
Brian, William R., et al.. (2009). Pharmacokinetic assessment of a five‐probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A. British Journal of Clinical Pharmacology. 68(6). 928–935. 128 indexed citations
19.
Hansel, Boris, Catherine Nicolle, Florent Lalanne, et al.. (2007). Effect of low-fat, fermented milk enriched with plant sterols on serum lipid profile and oxidative stress in moderate hypercholesterolemia. American Journal of Clinical Nutrition. 86(3). 790–796. 95 indexed citations
20.
Reginster, J.-Y., Yves Donazzolo, N Brion, & R. Lins. (2000). Estradiol pharmacokinetics after transdermal application of patches to postmenopausal women: matrix versus reservoir patches. Climacteric. 3(3). 168–175. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026